New open access journal: Allergy, Asthma & Clinical Immunology

BioMed Central has commenced publication of the following open access journal:

Title: Allergy, Asthma & Clinical Immunology
Editor(s)-in-chief: Richard WarringtonWade Watson, Harold Kim, Tom Bowen
Abbreviation: Allergy Asthma Clin Immunol
ISSN: 1710-1492

This journal the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), aims to further the understanding and treatment of allergic and immunologic disease. By offering a high-visibility forum for new insights and discussions, the journal will act as a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, immunologists and other physicians, healthcare workers, medical students and the public world wide.

The fields of allergy and clinical immunology concern human diseases in which disorders of the immune system play a significant role. It is considered that diseases of the immune system are best understood through a clear grasp of normal immune mechanisms and the ways in which these processes become dysfunctional.

Allergy, Asthma & Clinical Immunology will report on basic research and clinically applied studies in the following areas and other related topics: – asthma and occupational lung disease
– rhinoconjunctivitis and rhinosinusitis
– drug hypersensitivity
– allergic skin diseases
– urticaria and angioedema
– venom hypersensitivity
– anaphylaxis and food allergy
– immunotherapy
– immune modulators and biologics
– immune deficiency and autoimmunity
– T cell and B cell functions
– regulatory T cells
– natural killer cells
– mast cell and eosinophil functions
– complement abnormalities

If you would like further information about BioMed Central’s open access journals, please visit, or contact [email protected].